![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 45, 42790-42794, November 8, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Department of Molecular Medicine and Institute of Biotechnology, University of Texas Health Science Center, San Antonio, Texas 78254-3207
Received for publication, August 6, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Human Rad51 (hRad51) and Rad54 proteins are key
members of the RAD52 group required for homologous
recombination. We show an ability of hRad54 to promote transient
separation of the strands in duplex DNA via its ATP hydrolysis-driven
DNA supercoiling function. The ATPase, DNA supercoiling, and DNA strand
opening activities of hRad54 are greatly stimulated through an
interaction with hRad51. Importantly, we demonstrate that hRad51 and
hRad54 functionally cooperate in the homologous DNA pairing reaction
that forms recombination DNA intermediates. Our results should provide
a biochemical model for dissecting the role of hRad51 and hRad54 in
recombination reactions in human cells.
In eukaryotic organisms, the repair of DNA double-stranded breaks
by homologous recombination is mediated by a group of evolutionarily conserved genes known as the RAD52 epistasis group. Members
of the RAD52 group (RAD51, RAD52,
RAD54, RAD55, RAD57, RAD59,
and RDH54/TID1) were first uncovered in genetic
screens in the budding yeast Saccharomyces cerevisiae (1,
2). In mammals, the efficiency of homology-directed recombinational DNA
repair is modulated by the tumor suppressors BRCA1 and BRCA2 (3),
providing a compelling link between this DNA repair pathway and the
suppression of tumor formation. The involvement of the homologous
recombination machinery in the maintenance of genome stability and
tumor suppression underscores the need for deciphering the action
mechanism of this machinery.
During the recombinational repair of DNA double-stranded breaks, a
single-stranded DNA intermediate is utilized by the recombination machinery to invade a DNA homolog, most often the sister chromatid, to
form a DNA joint molecule referred to as a D-loop (2).
D-Loop formation is critical for subsequent steps in the
recombination reaction, which include repair DNA synthesis and
resolution of recombination intermediates (1, 2), that lead to the
restoration of the integrity of the injured chromosome.
In the past several years, biochemical studies have begun to shed light
on the functions of the human RAD52 group proteins in DNA
joint formation. Much of the published work has centered on the human
Rad51 (hRad51)1 protein,
which is structurally related to the Escherichia coli recombinase enzyme RecA (4). Like RecA, hRad51 assembles into a
right-handed filament on single-stranded (ss) DNA in a reaction that is
dependent on ATP binding (reviewed in Ref. 5). Importantly, hRad51
protein has been shown to have DNA pairing and strand exchange activities that yield DNA joints between homologous ssDNA and double-stranded DNA substrates (6-8). The homologous pairing and strand exchange function of hRad51 is augmented by replication protein A (RPA), a heterotrimeric single-stranded DNA binding factor (6, 8), by hRad52 protein (9), and by the Rad51B-Rad51C heterodimeric complex (10), which is the functional equivalent of the
yeast Rad55-Rad57 complex (11).
The RAD54 encoded product belongs to the Swi2/Snf2
protein family (12). Purified hRad54 exhibits DNA-dependent
ATPase and DNA supercoiling activities (13-15). However, the manner in
which hRad54 influences the hRad51-mediated recombination reaction has remained mysterious. Here we report our biochemical studies that show
functional interactions between hRad51 and hRad54 in DNA supercoiling
and homologous DNA pairing reactions. We discuss how hRad51 and hRad54
cooperate to make DNA joints during recombination processes.
Anti-Rad54 Antibodies--
The first 238 amino acid residues of
the human Rad54 protein were fused to glutathione
S-transferase in the vector pGEX-3X. The fusion protein was
expressed in E. coli strain BL21 (DE3) and purified from
inclusion bodies by preparative denaturing polyacrylamide gel
electrophoresis and used as antigen for raising polyclonal antibodies
in rabbits. The same antigen was covalently conjugated to cyanogen
bromide-activated Sepharose 4B and used as affinity matrix to purify
the antibodies from rabbit antisera, as described (16).
Rad54 Expression and Purification--
A recombinant baculovirus
containing the cloned hRad54 cDNA with an added FLAG
epitope at the C terminus was generated. HighFive insect cells were
infected with the recombinant baculovirus at a multiplicity of
infection of 10 and harvested after 48 h of incubation. An extract
was prepared from 500 ml of insect cell culture (5 × 108 cells) using a French Press in 60 ml of cell breakage
buffer (50 mM Tris-HCl, pH 7.5, 2 mM EDTA, 10%
sucrose, 200 mM KCl, 1 mM
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride,
and the following protease inhibitors at 3 µg/ml each: aprotinin,
chymostatin, leupeptin, and pepstatin). After centrifugation
(100,000 × g for 60 min), the clarified extract was
loaded onto a Q-Sepharose column (10-ml matrix). The flow-through
fraction from the Q column was fractionated in a
sulfopropyl-Sepharose column (10-ml matrix) with a 50-ml, 0-700
mM KCl gradient in K buffer (20 mM
KH2PO4 at pH 7.4, 0.5 mM EDTA, 1 mM dithiothreitol, and 10% glycerol). Fractions containing
the peak of hRad54 were pooled and loaded onto a 1-ml
Macro-hydroxyapatite (Bio-Rad) column, which was eluted with 30 ml of
0-300 mM KH2PO4 in K buffer. The
peak fractions were pooled and mixed with 1.5 ml of Anti-FLAG M2
agarose (Sigma) and rocked for 3 h at 4 °C. The FLAG agarose
was washed three times with 3 ml of 150 mM KCl in buffer K
before eluting hRad54 using the same buffer containing 1 mg/ml of the
FLAG peptide (Sigma). hRad54 (~1 mg) eluted from the FLAG matrix was
concentrated in a Centricon-30 microconcentrator to 5 mg/ml and stored
in small aliquots at Rad51 and hrad51 K133R Proteins--
The hRad51 protein
was expressed in the E. coli RecA-deficient strain BLR (DE3)
and purified to near homogeneity using our previously described
procedure (8). The hrad51 K133R mutant was expressed and purified to
near homogeneity in exactly the same way.
Topoisomerase I--
E. coli topoisomerase I was
purified to near homogeneity from the E. coli strain JM101
with plasmid pJW312-sal containing the topA gene
under the Lac promoter, as described (17).
Binding of hRad54 to Affi-hRad51 Beads--
Purified hRad51 and
bovine serum albumin (BSA) were coupled to Affi-Gel 15 beads at 4 °C
following the instructions of the manufacturer (Bio-Rad). The resulting
matrices contained 4 and 12 mg/ml hRad51 and BSA, respectively.
Purified hRad54 (1.2 µg) was mixed with 5 µl of Affi-Rad51 or
Affi-BSA at 4 °C for 30 min in 30 µl of buffer containing 100 mM KCl and 0.1% Triton X-100 by constant tapping. The
beads were washed twice with 50 µl of the same buffer before being
treated with 30 µl of 2% SDS at 37 °C for 5 min to elute the
bound hRad54. The various fractions (4 µl each) were analyzed by
immunoblotting to determine their content of hRad54.
DNA Substrates--
Topologically relaxed ATPase Assay--
The hRad54 protein (60 nM) was
incubated with replicative form I DNA Supercoiling and DNA Strand-opening
Reactions--
Increasing amounts of hRad54 were incubated with 80 ng
of relaxed D-Loop Reaction--
For the time course reactions
(25 µl, final volume) in Fig. 5, hRad51 or hrad51 K133R (800 nM) was incubated with the 5'-labeled ss oligonucleotide
(2.5 µM nucleotides) for 3 min at 37 °C in 22 µl of
reaction buffer (20 mM Tris-HCl, pH 7.4, 100 µg/ml BSA, 1.5 mM MgCl2, 2 mM ATP, and the
ATP-generating system described above). This was followed by the
addition of hRad54 (120 nM) in 1 µl and incubation at
23 °C for 2 min. The reaction was completed by adding the
pBluescript SK replicative form DNA (35 µM base pairs) in
2 µl. The reaction mixture was incubated at 30 °C, and 3.8-µl
aliquots were withdrawn at the indicated times, deproteinized, and run
in 1% agarose gels in TAE buffer. The gels were dried and the levels
of D-loop were quantified by phosphorimage analysis. The
reactions in which ATP, hRad51, or hRad54 was omitted or ATP was
replaced by ATP Human Recombination Factors--
Human Rad51 was expressed in a
recA-E. coli strain and purified to near homogeneity
as described previously (8). The hrad51 K133R mutant, which harbors the
change of the conserved lysine residue in the Walker type A nucleotide
binding motif to arginine, was also similarly expressed and purified.
In agreement with previously published results (20), hrad51 K133R has
negligible ATPase activity compared with wild type hRad51 (data not
shown). We cloned the human RAD54 cDNA from a testis
cDNA library using the polymerase chain reaction. The entire cloned
hRAD54 cDNA was sequenced to ensure that it agreed with
the published sequence (21). We tagged hRad54 protein with a FLAG
epitope at the carboxyl terminus and expressed it in insect cells by
the use of a recombinant baculovirus (Fig.
1A). We obtained ~1 mg of
nearly homogeneous hRad54 (Fig. 1B) from 500 ml of insect
cell culture by a combination of conventional column chromatography and
affinity binding to an antibody specific for the FLAG epitope. The
purified hRad54 has a level of DNA-dependent ATPase very
similar to that described in the literature (13) (see later).
hRad54 Physically Interacts with hRad51--
Golub et
al. (22) found that the amino terminus of hRad54 can bind hRad51
in in vitro analyses and also in the yeast two-hybrid system. However, in mouse embryonic stem cells, association of mRad51 and mRad54 requires prior treatment of cells with a DNA damaging
agent (14). To examine whether purified hRad54 physically interacts
with hRad51, we coupled hRad51 to Affi-Gel beads to use as affinity
matrix for binding hRad54. As shown in Fig.
2, purified hRad54 was efficiently
retained on Affi-hRad51 beads but not on Affi-beads that contained BSA.
When a less purified hRad54 fraction (~25% hRad54) was used, hRad54,
but not the contaminating protein species, bound to the Affi-hRad51
beads (data not shown). The results thus indicate a direct and specific
interaction between hRad51 and hRad54.
DNA Supercoiling and DNA Strand Opening by hRad54--
Tan
et al. (14) showed an ability of hRad54 to alter the DNA
linking number of a nicked plasmid in the presence of DNA ligase. The
induction of DNA linking number change was dependent on ATP hydrolysis
by hRad54 (14). The same group also used scanning force microscopy to
provide evidence that hRad54 tracks on DNA when ATP is hydrolyzed (15).
A schematic depicting the basis for tracking-induced DNA supercoiling
by hRad54 is given in Fig. 3A.
The yRad54 protein also tracks on DNA and, as a result, generates
positive and negative supercoils in the DNA substrate. Removal of the
negative supercoils by treatment with E. coli topoisomerase I leads to the accumulation of positive supercoils and the formation of
an overwound DNA species called Form OW (18). Here we used the same
strategy to examine the ability of hRad54 to supercoil DNA. As shown in
Fig. 3B, in the presence of topoisomerase, purified hRad54
protein readily induces a linking number change in the DNA (18). The
DNA supercoiling reaction is dependent on ATP hydrolysis, as revealed
by its omission or substitution with a nonhydrolyzable analogue
(ATP
We asked whether the negative supercoils generated as a result of
hRad54 tracking on the DNA substrate (15) (Fig. 3, A and B) leads to transient DNA strand opening by examining the
sensitivity of a relaxed DNA template to the single-strand specific
nuclease P1, as per Van Komen et al. (18). Fig.
3C shows that incubation of topologically relaxed DNA with
hRad54 rendered the relaxed DNA substrate sensitive to P1 nuclease, as
indicated by the accumulation of nicked circular and linear DNA forms.
The DNA strand opening reaction is also completely dependent on ATP
hydrolysis (Fig. 3C).
Activities of hRad54 Are Stimulated by hRad51--
The results
presented here (Fig. 2) and elsewhere (22) have unveiled a specific
interaction between hRad51 and hRad54. We examined whether the hRad54
ATPase would be enhanced upon interaction with hRad51. As shown in Fig.
4A, a much higher rate of ATP
hydrolysis was seen when hRad54 was combined with hRad51. The fact that
yRad51 was ineffective in this reaction (Fig. 4A) indicates
that the action of hRad51 is specific. Although hRad51 is known to have a weak ATPase activity (23), the fact that the hrad51 K133R mutant
protein, which binds but does not hydrolyze ATP (20), was just as
effective in promoting ATP hydrolysis (data not shown) strongly
indicated that the increase in ATP hydrolysis was because of
enhancement of the hRad54 ATPase function.
We next asked whether the DNA supercoiling activity of hRad54 would
also be up-regulated by hRad51. The results showed that hRad51
stimulates the supercoiling reaction, as indicated by a much higher
level of Form OW DNA (Fig. 4B). Because negative
supercoiling generated by hRad54 leads to DNA strand opening (Fig.
3C), we thought that hRad51 might also promote this
activity. Indeed, the inclusion of hRad51 greatly elevated the nicking
of the relaxed DNA substrate by P1 nuclease (Fig. 4C). Even
with the inclusion of hRad51, no Form OW DNA or nicking of DNA was seen
when ATP was omitted or substituted by the nonhydrolyzable analogues
ATP hRad51 and hRad54 Cooperate in Homologous DNA Pairing--
The
RecA/Rad51 class of general recombinases is central to recombination
processes by virtue of their ability to catalyze the homologous DNA
pairing reaction that yields heteroduplex DNA joints (2, 24). Because
hRad51 and hRad54 physically interact (22) (Fig. 2) and hRad51 enhances
the various activities of hRad54 (Fig. 4), it was of considerable
interest to examine the influence of hRad54 on hRad51-mediated
homologous DNA pairing.
The homologous pairing assay monitors the incorporation of a
32P-labeled single-stranded oligonucleotide into a
homologous supercoiled target (pBluescript) to give a
D-loop structure (Fig.
5A). As reported before (25)
and reiterated here (Fig. 5B), hRad51 by itself is not
particularly adept at forming D-loop. Importantly, the
inclusion of hRad54 rendered D-loop formation possible.
D-Loop formation by the combination of hRad51 and hRad54
requires ATP hydrolysis, because no D-loop was seen when
ATP was omitted or when it was replaced by either ATP It has been deduced from biochemical and scanning force microscopy
analyses that Rad54 tracks on DNA, producing positive supercoils ahead
of the protein movement and negative supercoils tailing it (15, 18). As
a result of interaction with hRad51, the ATPase, DNA
supercoiling, and DNA strand opening activities of Rad54 are greatly
enhanced (this work). Petukhova et al. (19) first
reported that yRad54 enhances homologous DNA pairing by yRad51. Here we have presented biochemical evidence that hRad51 and hRad54 also work in
concert to make DNA joints. Interestingly, the hRad51/hRad54-mediated D-loop reaction undergoes a rapid cycle of joint formation
and dissociation. We have speculated that ATP hydrolysis by hRad51 could have resulted in its turnover from the bound ssDNA. This might
have led to the transfer of hRad51/hRad54 to the displaced strand in
the D-loop to initiate a second round of homologous pairing
with the newly formed DNA joint. The presumed secondary pairing
reaction could have accounted for the dissociation of the initial
D-loop. Consistent with this hypothesis, the ATP
hydrolysis-defective hrad51 K133R mutant is much more adept at forming
D-loop than the wild type protein. Previously, studies in
yeast and chicken DT40 cells with the same Rad51 ATPase mutant have
shown that it is biologically active but that an increased level of
this mutant is needed for full complementation of the various
phenotypes of Rad51-deficient cells (20, 28). The fact that the hrad51
K133R mutant is even more effective than the wild type protein in the D-loop reaction strongly suggests that the slighted
biological efficacy (20, 28) and observed dominance (29) of this
protein are because of a reason other than a diminished ability to
mediate homologous pairing. The hrad51 K133R mutant may form a highly stable complex with DNA, thus reducing the effective concentration of
free protein available for recombination reactions. Importantly, our
biochemical results predict that other members of the RAD52 group may function to prevent reversal of the D-loop
reaction catalyzed by hRad51/hRad54.
Inactivation of the hRad54 ATPase activity impairs the ability to carry
out recombination in vivo (14), consistent with the premise
that the ATP hydrolysis-dependent DNA supercoiling and DNA
strand opening activities of hRad54 are germane for recombination. As
discussed here and elsewhere (15, 18, 30), it is likely that the DNA
strand opening activity of hRad54 promotes the acquisition of an
unwound DNA structure conducive for the formation of the nascent DNA
joint that links recombining chromosomes. The ability of hRad54 to pull
the incoming duplex molecule through its fold (i.e.
tracking) is also expected to enhance the rate at which the duplex can
be sampled by the hRad51-ssDNA nucleoprotein filament for homology.
Finally, it remains a distinct possibility that the dynamic DNA
topological changes induced by the combination of hRad51 and hRad54 are
critical for the remodeling of chromatin during recombination.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
70 °C.
X174 DNA was
prepared as described (18), and pBluescript SK DNA was made in E. coli DH5
and purified as described (19). The oligonucleotide
used in the D-loop reaction is complementary to positions
1932-2022 of the pBluescript SK DNA and had the sequence
5'-AAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTT-3'. This oligonucleotide was 5' end-labeled with [
-32P]ATP
and T4 polynucleotide kinase.
X174 DNA (30 µM base
pairs) and 1.5 mM [
-32P]ATP with or
without 400 nM hRad51 or yRad51 in 10 µl of reaction buffer (20 mM Tris-HCl, pH 7.4, 25 mM KCl, 1 mM dithiothreitol, 4 mM MgCl2, 100 µg/ml BSA) at 30 °C for the indicated times. The level of ATP
hydrolysis was determined by thin layer chromatography, as described
(19).
X174 DNA (12 µM nucleotides) for 2 min at
23 °C in 12 µl of reaction buffer (20 mM Tris-HCl, pH
7.4, 5 mM MgCl2, 1 mM
dithiothreitol, 100 µM ATP, and an ATP-regenerating
system consisting of 10 mM creatine phosphatase and 28 µg/ml creatine kinase). Following the addition of 100 ng of E. coli topoisomerase I in 0.5 µl, the reactions were incubated for
10 min at 23 °C and then deproteinized by treatment with 0.5% SDS
and proteinase K (0.5 mg/ml) for 10 min at 37 °C. Samples were run
on 1% agarose gels in TAE buffer (35 mM Tris acetate, pH
7.4, 0.5 mM EDTA) at 23 °C and then stained with
ethidium bromide. In the experiment in Fig. 4B, the relaxed DNA was incubated with the indicated amounts of hRad51 and hRad54 for 2 min at 23 °C, followed by the addition of topoisomerase and a 10-min
incubation at 23 °C. For the P1 sensitivity experiments in Figs.
3C and 4C, the reactions were assembled in the
same manner except that 0.4 unit of P1 nuclease (Roche) was used
instead of topoisomerase. The DNA species were resolved in a 1%
agarose gel containing 10 µM ethidium bromide in TAE buffer.
S or AMP-PNP were scaled down 2-fold to a 12.5-µl
final volume, but they were otherwise assembled and processed in
exactly the same manner.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (41K):
[in a new window]
Fig. 1.
Purification of hRad54. A,
expression of hRad54 in insect cells. Extracts from uninfected insect
cells (lane 1) and from insect cells infected with the
recombinant hRad54 baculovirus (lane 2) were probed with
affinity-purified anti-hRad54 antibodies. In lane 3, 100 ng
of purified hRad54 was also subjected to immunoblotting. B,
purified hRad54 protein (1 µg) was run in an 8% denaturing
polyacrylamide gel and stained with Coomassie Blue.

View larger version (31K):
[in a new window]
Fig. 2.
hRad54 interacts with hRad51. Purified
hRad54 (1.2 µg) was mixed with Affi-beads containing either BSA
(Affi-BSA) or hRad51 (Affi-Rad51) in 30 µl and washed twice with 50 µl buffer, followed by treatment of the beads with 30 µl of SDS to
elute bound hRad54. The starting material (I), supernatant
(S), the two washes (W1 and W2), and
the SDS eluate (E), 4 µl each, were subjected to
immunoblotting to determine their hRad54 content.

View larger version (40K):
[in a new window]
Fig. 3.
hRad54 supercoils DNA and promotes DNA strand
opening. A, basis for hRad54-induced supercoiling, as
per Ristic et al. (15) and Van Komen et al. (18).
The free energy from ATP hydrolysis fuels the tracking of a hRad54
oligomer on DNA, producing a positively supercoiled domain ahead of
protein movement and a negatively supercoiled domain behind.
B, increasing amounts of hRad54 (200, 400, and 750 nM in lanes 3-5, respectively) were incubated
with topologically relaxed DNA (20 µM nucleotides) and
E. coli topoisomerase I in buffer that contained ATP. The
highest amount of hRad54 (750 nM) was also incubated with
the DNA substrate in the absence of topoisomerase (lane 6)
and in the presence of topoisomerase but with the omission of ATP
(lane 7) or the substitution of ATP by ATP
S
(
-S; lane 8) and AMP-PNP (PNP;
lane 9). DNA alone (lane 1) or DNA incubated with
topoisomerase (lane 2) was also included. The reaction
mixtures were run in a 1% agarose gel, which was treated with ethidium
bromide to reveal the DNA species. C, increasing amounts of
hRad54 (200, 400, and 750 nM in lanes 3-5,
respectively) were incubated with topologically relaxed DNA (20 µM nucleotides) and P1 nuclease in buffer that contained
ATP. The highest amount of hRad54 (750 nM) was also
incubated with the DNA substrate in the absence of P1 (lane
6) and in the presence of P1 but with the omission of ATP
(lane 7) or the substitution of ATP by ATP
S
(
-S; lane 8) and AMP-PNP (PNP;
lane 9). DNA alone (lane 1) and DNA incubated
with P1 in the absence of hRad54 (lane 2) were also
included. The reaction mixtures were run in a 1% agarose gel
containing 10 µM ethidium bromide.
S or AMP-PNP) (Fig. 3B).

View larger version (44K):
[in a new window]
Fig. 4.
The hRad54 activities are stimulated by
hRad51. A, hRad54 was incubated with
X replicative
form I DNA (30 µM nucleotides) and 1.5 mM
[
-32P]ATP for the indicated times, and the level of
ATP hydrolysis was quantified by thin layer chromatography. ATPase
activity was also measured for hRad51 alone, yRad51 alone, and the
combinations of hRad54/hRad51 and hRad54/yRad51. The protein
concentrations were as follows: hRad54, 60 nM; hRad51, 400 nM; yRad51, 400 nM. In every case, negligible
ATP hydrolysis was seen when DNA was omitted (data not shown).
B, relaxed DNA (20 µM nucleotides) was
incubated with hRad54 (75 nM in lanes 2 and
4-9) and hRad51 (80, 160, and 240 nM in
lanes 4-6, respectively) in the presence of ATP and
E. coli topoisomerase I. The highest amount of hRad51 (240 nM) was incubated with substrate and topoisomerase I but
without hRad54 (lane 3) and also with hRad54 (75 nM) but with the omission of ATP (lane 7) or its
substitution with ATP
S (
-S; lane 8) or
AMP-PNP (PNP; lane 9). DNA alone was analyzed in
lane 1. After deproteinization, the reaction mixtures were
run in a 1% agarose gel, which was treated with ethidium bromide to
stain the DNA species. C, relaxed DNA was incubated with
hRad54 (75 nM in lanes 2 and 4-9)
and hRad51 (80, 160, and 240 nM in lanes 4-6,
respectively) in the presence of ATP and P1 nuclease. The highest
amount of hRad51 (240 nM) was incubated with substrate and
P1 but without hRad54 (lane 3) and also with hRad54 (75 nM) but with the omission of ATP (lane 7) or its
substitution with ATP
S (
-S; lane 8) or
AMP-PNP (PNP; lane 9). DNA alone was run in
lane 1. Analysis was carried out in a 1% agarose gel that
contained 10 µM ethidium bromide.
S and AMP-PNP (Fig. 4, B and C). Thus, the
results revealed that hRad51 markedly stimulates the ability of Rad54
to supercoil DNA and unwind DNA strands. The hrad51 K133R protein was
just as effective as wild type hRad51 in enhancing the DNA supercoiling
and strand opening activities of hRad54 (data not shown). Furthermore,
we found that yRad51 does not stimulate the hRad54 activities (data not
shown), thus indicating a high degree of specificity in the hRad51 action.
S or AMP-PNP
(Fig. 5B). Significantly, the time course revealed a cycle
of rapid formation and disruption of D-loop, such that the
D-loop level reached its maximum by 1 min but declined
rapidly thereafter (Fig. 5, B and D). In fact, by
the reaction end point of 6 min, little or no D-loop
remained (Fig. 5, B and D). Such a cycle of
D-loop synthesis and reversal seems to be a general
characteristic for the RecA/Rad51 class of recombinases (26, 27).
Because the RecA-ssDNA nucleoprotein filament disassembles upon ATP
hydrolysis (24), we considered the possibility that the dissociation of
D-loop seen here (Fig. 5B) could be related to
ATP hydrolysis-mediated turnover of hRad51. To test this premise, we
used the hrad51 K133R mutant protein, which binds but does not
hydrolyze ATP (20), with hRad54 in the D-loop assay. True
to prediction, with hrad51 K133R, the D-loop amount
increased with time, reaching a much higher final level than when
hRad51 was used (Fig. 5, B-D); by 4 min, 23% of
the input ssDNA or 55% of the pBluescript plasmid DNA had been
incorporated into the D-loop structure. As expected, with
both hRad51/hRad54 and hrad51 K133R/hRad54, formation of
D-loop required both the 90-mer substrate and the
pBluescript target, and substitution of the pBluescript DNA with the
heterologous
X174 DNA completely abolished D-loop
formation (data not shown).

View larger version (38K):
[in a new window]
Fig. 5.
D-Loop formation by hRad51 and
hRad54. A, schematic of assay. A radiolabeled 90-mer
DNA pairs with a homologous duplex target to yield a
D-loop. B, hRad51 alone (lanes 2 and
3), hRad54 alone (lanes 4 and 5), and
the combination of hRad51 and hRad54 (lanes 6-14) were
incubated at 30 °C for the indicated times with the DNA substrates
in the presence of ATP (lanes 2-11), ATP
S
(
S; lane 13), or AMP-PNP (PNP;
lane 14) or in the absence of nucleotide (lane
12). In lane 1, the DNA substrates were incubated in
buffer without protein. The protein and DNA concentrations were as
follows: hRad51, 800 nM; hRad54, 120 nM; 90-mer
oligonucleotide, 2.5 µM nucleotides or 27.7 nM oligonucleotide; pBluescript supercoiled DNA, 35 µM base pairs or 11.6 nM plasmid.
C, the homologous pairing activity of hrad51 K133R was
examined with hRad54 as described for hRad51 above. D, the
results in lanes 6-11 of B (
) and
C (
) were graphed.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENT |
|---|
We thank Toshiyuki Habu for helping with plasmid constructions.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grants GM57814 and CA81020.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported in part by United States Army Predoctoral Fellowship
DAMD17-01-1-0412.
§ Supported in part by United States Army Predoctoral Fellowship DAMD17-01-1-0414.
¶ Supported in part by National Institutes of Health Training Grant T32AG00165. Present address: NIDDK, National Institutes of Health, Bldg. 10, Rm. 9D17, 9000 Rockville Pike, Bethesda, MD 20892.
To whom correspondence should be addressed. Tel.:
210-567-7216; Fax: 210-567-7277; E-mail: sung@uthscsa.edu.
Published, JBC Papers in Press, August 29, 2002, DOI 10.1074/jbc.M208004200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
hRad51, human Rad51;
yRad51, yeast Rad51;
ss, single-stranded;
BSA, bovine serum albumin;
AMP-PNP, adenosine 5'-(
,
-imino)triphosphate;
ATP
S, adenosine
5'-3-O-(thio)triphosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Paques, F.,
and Haber, J. E.
(1999)
Microbiol. Mol. Biol. Rev.
63,
349-404 |
| 2. | Sung, P., Trujillo, K., and Van Komen, S. (2000) Mutat. Res. 451, 257-275[Medline] [Order article via Infotrieve] |
| 3. | Pierce, A. J., Stark, J. M., Araujo, F. D., Moynahan, M. E., Berwick, M., and Jasin, M. (2001) Trends Cell Biol. 11, S52-59[Medline] [Order article via Infotrieve] |
| 4. | Shinohara, A., Ogawa, H., Matsuda, Y., Ushio, N., Ikeo, K., and Ogawa, T. (1993) Nat. Genet. 4, 239-243[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Yu, X., Jacobs, S. A., West, S. C., Ogawa, T., and Egelman, E. H. (2001) Proc. Natl. Acad. Sci. U. S. A. 17, 8419-8424 |
| 6. | Baumann, P., Benson, F. E., and West, S. C. (1996) Cell 87, 757-766[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Gupta, R. C.,
Bazemore, L. R.,
Golub, E. I.,
and Radding, C. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
463-468 |
| 8. |
Sigurdsson, S.,
Trujillo, K.,
Song, B.-W.,
Stratton, S.,
and Sung, P.
(2001)
J. Biol. Chem.
276,
8798-8806 |
| 9. | Benson, F. E., Baumann, P., and West, S. C. (1998) Nature 391, 401-404[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Sigurdsson, S.,
Van Komen, S.,
Bussen, W.,
Schild, D.,
Albala, J. S.,
and Sung, P.
(2001)
Genes Dev.
15,
3308-3318 |
| 11. |
Sung, P.
(1997)
Genes Dev.
11,
1111-1121 |
| 12. |
Eisen, J. A.,
Sweder, K. S.,
and Hanawalt, P. C.
(1995)
Nucleic Acids Res.
23,
2715-2723 |
| 13. |
Swagemakers, S. M. A.,
Essers, J.,
de Wit, J.,
Hoeijmakers, J. H. J.,
and Kanaar, R.
(1998)
J. Biol. Chem.
273,
28292-28297 |
| 14. | Tan, T. L., Essers, J., Citterio, E., Swagemakers, S. M., de Wit, J., Benson, F. E., Hoeijmakers, J. H., and Kanaar, R. (1999) Curr. Biol. 9, 325-328[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Ristic, D., Wyman, C., Paulusma, C., and Kanaar, R. (2001) Proc. Natl. Acad. Sci. U. S. A. 84, 8454-8460 |
| 16. |
Sung, P.,
Prakash, L.,
Matson, S. W.,
and Prakash, S.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
8951-8955 |
| 17. | Lynn, R. M., and Wang, J. C. (1989) Proteins 6, 231-239[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Van Komen, S., Petukhova, G., Sigurdsson, S., Stratton, S., and Sung, P. (2000) Mol. Cell 6, 563-572[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Petukhova, G., Stratton, S., and Sung, P. (1998) Nature 393, 91-94[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Morrison, C.,
Shinohara, A.,
Sonoda, E.,
Yamaguchi-Iwai, Y.,
Takata, M.,
Weichselbaum, R. R.,
and Takeda, S.
(1999)
Mol. Cell. Biol.
19,
6891-6897 |
| 21. | Kanaar, R., Troelstra, C., Swagemakers, S. M., Essers, J., Smit, B., Franssen, J. H., Pastink, A., Bezzubova, O. Y., Buerstedde, J. M., Clever, B., Heyer, W. D., and Hoeijmakers, J. H. (1996) Curr. Biol. 6, 828-838[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Golub, E. I.,
Kovalenko, O. V.,
Gupta, R. C.,
Ward, D. C.,
and Radding, C. M.
(1997)
Nucleic Acids Res.
25,
4106-4110 |
| 23. | Benson, F. E., Stasiak, A., and West, S. C. (1994) EMBO J. 13, 5764-5771[Medline] [Order article via Infotrieve] |
| 24. | Bianco, P. R., Tracy, R. B., and Kowalczykowski, S. C. (1998) Front. Biosci. 3, D580-603 |
| 25. | Mazin, A. V., Zaitseva, E., Sung, P., and Kowalczykowski, S. C. (2000) EMBO J. 19, 1148-1156[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Shibata, T., Ohtani, T., Iwabuchi, M., and Ando, T. (1982) J. Biol. Chem. 10, 13981-13986 |
| 27. | Mcllwraith, M. J., Van Dyck, E., Masson, J. Y., Stasiak, A. Z., Stasiak, A., and West, S. C. (2000) J. Mol. Biol. 304, 151-164[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Sung, P.,
and Stratton, S. A.
(1996)
J. Biol. Chem.
271,
27983-27986 |
| 29. |
Stark, J. M., Hu, P.,
Pierce, A. J.,
Moynahan, M. E.,
Ellis, N.,
and Jasin, M.
(2002)
J. Biol. Chem.
277,
20185-20194 |
| 30. | Mazin, A. V., Bornarth, C. J., Solinger, J. A., Heyer, W. D., and Kowalczykowski, S. C. (2000) Mol. Cell 6, 583-592[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
V. Gangavarapu, S. Prakash, and L. Prakash Requirement of RAD52 Group Genes for Postreplication Repair of UV-Damaged DNA in Saccharomyces cerevisiae Mol. Cell. Biol., November 1, 2007; 27(21): 7758 - 7764. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chi, J. San Filippo, M. G. Sehorn, G. V. Petukhova, and P. Sung Bipartite stimulatory action of the Hop2-Mnd1 complex on the Rad51 recombinase Genes & Dev., July 15, 2007; 21(14): 1747 - 1757. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, X.-P. Zhang, J. A. Solinger, K. Kiianitsa, X. Yu, E. H. Egelman, and W.-D. Heyer Rad51 and Rad54 ATPase activities are both required to modulate Rad51-dsDNA filament dynamics Nucleic Acids Res., June 22, 2007; (2007) gkm412v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Fung, G. S. Fortin, S. E. Peterson, and L. S. Symington The rad51-K191R ATPase-Defective Mutant Is Impaired for Presynaptic Filament Formation Mol. Cell. Biol., December 15, 2006; 26(24): 9544 - 9554. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Otterlei, P. Bruheim, B. Ahn, W. Bussen, P. Karmakar, K. Baynton, and V. A. Bohr Werner syndrome protein participates in a complex with RAD51, RAD54, RAD54B and ATR in response to ICL-induced replication arrest J. Cell Sci., December 15, 2006; 119(24): 5137 - 5146. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sarai, W. Kagawa, T. Kinebuchi, A. Kagawa, K. Tanaka, K. Miyagawa, S. Ikawa, T. Shibata, H. Kurumizaka, and S. Yokoyama Stimulation of Dmc1-mediated DNA strand exchange by the human Rad54B protein Nucleic Acids Res., September 11, 2006; 34(16): 4429 - 4437. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-D. Heyer, X. Li, M. Rolfsmeier, and X.-P. Zhang Rad54: the Swiss Army knife of homologous recombination? Nucleic Acids Res., September 10, 2006; 34(15): 4115 - 4125. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vasileva, R. M. Linden, and R. Jessberger Homologous recombination is required for AAV-mediated gene targeting Nucleic Acids Res., July 5, 2006; 34(11): 3345 - 3360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wesoly, S. Agarwal, S. Sigurdsson, W. Bussen, S. Van Komen, J. Qin, H. van Steeg, J. van Benthem, E. Wassenaar, W. M. Baarends, et al. Differential Contributions of Mammalian Rad54 Paralogs to Recombination, DNA Damage Repair, and Meiosis Mol. Cell. Biol., February 1, 2006; 26(3): 976 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. LeRoy, R. Carroll, S. Kyin, M. Seki, and M. D. Cole Identification of RecQL1 as a Holliday junction processing enzyme in human cell lines Nucleic Acids Res., October 31, 2005; 33(19): 6251 - 6257. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hamimes, H. Arakawa, A. Z. Stasiak, A. M. Kierzek, S. Hirano, Y.-G. Yang, M. Takata, A. Stasiak, J.-M. Buerstedde, and E. Van Dyck RDM1, a Novel RNA Recognition Motif (RRM)-containing Protein Involved in the Cell Response to Cisplatin in Vertebrates J. Biol. Chem., March 11, 2005; 280(10): 9225 - 9235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raschle, S. Van Komen, P. Chi, T. Ellenberger, and P. Sung Multiple Interactions with the Rad51 Recombinase Govern the Homologous Recombination Function of Rad54 J. Biol. Chem., December 10, 2004; 279(50): 51973 - 51980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Stark, A. J. Pierce, J. Oh, A. Pastink, and M. Jasin Genetic Steps of Mammalian Homologous Repair with Distinct Mutagenic Consequences Mol. Cell. Biol., November 1, 2004; 24(21): 9305 - 9316. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Kumar and R. C. Gupta Strand exchange activity of human recombination protein Rad52 PNAS, June 29, 2004; 101(26): 9562 - 9567. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Alexiadis, A. Lusser, and J. T. Kadonaga A Conserved N-terminal Motif in Rad54 Is Important for Chromatin Remodeling and Homologous Strand Pairing J. Biol. Chem., June 25, 2004; 279(26): 27824 - 27829. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smirnova, S. Van Komen, P. Sung, and H. L. Klein Effects of Tumor-associated Mutations on Rad54 Functions J. Biol. Chem., June 4, 2004; 279(23): 24081 - 24088. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Trojanek, T. Ho, L. Del Valle, M. Nowicki, J. Y. Wang, A. Lassak, F. Peruzzi, K. Khalili, T. Skorski, and K. Reiss Role of the Insulin-Like Growth Factor I/Insulin Receptor Substrate 1 Axis in Rad51 Trafficking and DNA Repair by Homologous Recombination Mol. Cell. Biol., November 1, 2003; 23(21): 7510 - 7524. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Adachi, H. Suzuki, S. Iiizumi, and H. Koyama Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193: IMPLICATIONS FOR THE REPAIR OF TOPOISOMERASE II-MEDIATED DNA DAMAGE J. Biol. Chem., September 19, 2003; 278(38): 35897 - 35902. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Jaco, P. Munoz, F. Goytisolo, J. Wesoly, S. Bailey, G. Taccioli, and M. A. Blasco Role of Mammalian Rad54 in Telomere Length Maintenance Mol. Cell. Biol., August 15, 2003; 23(16): 5572 - 5580. [Abstract] [Full Text] [PDF] |
||||
![]() |